Medical Affairs teams face rising content volumes, shrinking review windows, and increased regulatory pressure. IQVIA helps you reduce review cycles, accelerate approvals, and maintain uncompromising quality.
Talk to an MLR expert using the contact us button below.
Teams are producing more content than ever before—but review processes haven’t kept pace. IQVIA can help you streamline MLR workflows, so your teams spend less time navigating reviews and more time focusing on scientific strategy and customer engagement.
An early assessment and insight-driven approach reduces cycle times, improves content quality, and enables predictable, compliant approvals.
With the explosion of content required for the multichannel campaigns globally, more time is spent on the review and approval of materials.
IQVIA Pharma Review can release you of this burden, allowing Medical Affairs teams to focus on core strategic activities.
There is an increasing need to disseminate data quickly and at appropriate moments throughout the year.
IQVIA Pharma Review’s global team empowers customers to scale as required to address the complexity, frequency, and time-sensitive nature of projects. We can review any type of content, from materials planned for delivery throughout the year to real‑time, at‑pace support during global events. Our team quickly adapts to the evolving needs of our clients, enabling streamlined delivery of materials that resonate with and engage target audiences.
Speed and accuracy are core elements of any MLR programme.
IQVIA Pharma Review aims to deliver approved, compliant content to market in an expedited manner. Our aim is to deliver results within 48 hours whenever possible. Whether it’s a review round or final asset approval, our team works closely with you to turn materials around as quickly and efficiently as possible.
Quality assured, accurate processes to deliver content to market quickly.
MLR processes haven’t kept up with the modern day needs for quick, modular content.
IQVIA Pharma review can provide structured and effective support across material review, medical approval, and lifecycle management to unburden customers from complex MLR process. IQVIA Pharma Review can support in the following ways
How often have campaigns and materials ended up in multiple rounds of review?
Core Claims workshops by IQVIA Pharma Review build learning with internal teams, ensuring all parties understand the key claims and how they are to be used.
Partners benefit from tailored programs through:
As content demands grow, Medical Affairs teams need review processes that keep pace without compromising quality. IQVIA provides scalable, insight-led MLR support that removes bottlenecks and accelerates compliant approvals.
Discover through each dropdown on the right how IQVIA Pharma Review is the proven trusted partner to deliver MLR review.
IQVIA Pharma Review delivers expert-led content development for global Medical Affairs professionals. Its content review is consistently accurate, trusted, and compliant empowering clients to focus on their business strategy.
95% of our clients accelerate launches and campaigns with industry-leading turnaround times that reduce delays and keep your teams moving.
8,000 materials reviewed monthly. Benefit from unmatched scale and pattern recognition, enabling proactive risk identification and consistent, high-quality review.
Materials certified and approved for use monthly. Ensure every approval is audit-ready with rigorous quality controls and expert oversight.
5 regions or countries in which localizing MLR with international expertise across multiple countries managing content local, regional and global level.
Our global network of 100+ subject matter experts (SMEs) supports the review of materials across languages and regions.
Our subject matter experts support more than 50 therapy areas globally
.svg){kind=icon}
